AR112346A1 - Derivados de [1,2,4]triazolo - Google Patents

Derivados de [1,2,4]triazolo

Info

Publication number
AR112346A1
AR112346A1 ARP180102122A AR112346A1 AR 112346 A1 AR112346 A1 AR 112346A1 AR P180102122 A ARP180102122 A AR P180102122A AR 112346 A1 AR112346 A1 AR 112346A1
Authority
AR
Argentina
Prior art keywords
triazolo
derivatives
ch2ch2
cyclopropyl
ch2ch2ch2
Prior art date
Application number
Other languages
English (en)
Spanish (es)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of AR112346A1 publication Critical patent/AR112346A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14Ortho-condensed systems
    • C07D491/147Ortho-condensed systems the condensed system containing one ring with oxygen as ring hetero atom and two rings with nitrogen as ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ARP180102122 2017-08-10 2018-07-27 Derivados de [1,2,4]triazolo AR112346A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201762543427P 2017-08-10 2017-08-10

Publications (1)

Publication Number Publication Date
AR112346A1 true AR112346A1 (es) 2019-10-16

Family

ID=63364164

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP180102122 AR112346A1 (es) 2017-08-10 2018-07-27 Derivados de [1,2,4]triazolo

Country Status (8)

Country Link
US (1) US11401274B2 (enExample)
EP (1) EP3665174B1 (enExample)
JP (1) JP6834057B2 (enExample)
CN (1) CN110914273B (enExample)
AR (1) AR112346A1 (enExample)
ES (1) ES2895969T3 (enExample)
TW (1) TW201920188A (enExample)
WO (1) WO2019032383A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113072453A (zh) * 2021-04-08 2021-07-06 红宝丽集团股份有限公司 一种2-氨基环烷醇的制备方法
WO2025059641A1 (en) 2023-09-14 2025-03-20 Eli Lilly And Company Pde1 inhibitors

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4354027A (en) 1980-05-19 1982-10-12 Usv Pharmaceutical Corporation Triazoloquinoxalin-4-ones
FR2662163A1 (fr) * 1990-05-16 1991-11-22 Lipha Nouvelles 8-amino-1,2,4-triazolo(4,3-a) pyrazines, procedes de preparation et medicaments les contenant.
CN1285834A (zh) 1997-11-11 2001-02-28 小野药品工业株式会社 稠合吡嗪化合物
DE602006021044D1 (de) * 2005-09-29 2011-05-12 Glaxo Group Ltd Pyrazoloä3,4-büpyridinverbindungen und ihre verwendung als pde4-inhibitoren
ES2599054T3 (es) * 2006-12-13 2017-01-31 Aska Pharmaceutical Co., Ltd. Derivados de quinoxalina
WO2008103357A1 (en) 2007-02-21 2008-08-28 E. I. Du Pont De Nemours And Company Fungicidal tricyclic 1,2,4-triazoles
WO2012033101A1 (ja) * 2010-09-07 2012-03-15 アステラス製薬株式会社 キノキサリン化合物
IN2015DN00334A (enExample) 2012-06-18 2015-06-12 Dart Neuroscience Cayman Ltd
AR107456A1 (es) 2016-02-12 2018-05-02 Lilly Co Eli Inhibidor de pde1
JOP20170164A1 (ar) 2016-08-25 2019-01-30 Lilly Co Eli مشتق ترايازولو بيرازينون مفيد كمثبط لـ pde1 بشري

Also Published As

Publication number Publication date
ES2895969T3 (es) 2022-02-23
EP3665174B1 (en) 2021-09-15
TW201920188A (zh) 2019-06-01
JP6834057B2 (ja) 2021-02-24
JP2020530023A (ja) 2020-10-15
CN110914273B (zh) 2023-05-16
WO2019032383A1 (en) 2019-02-14
CN110914273A (zh) 2020-03-24
US11401274B2 (en) 2022-08-02
US20210147437A1 (en) 2021-05-20
EP3665174A1 (en) 2020-06-17

Similar Documents

Publication Publication Date Title
DOP2020000102A (es) Compuestos útiles para inhibir a cdk7
CL2018000318A1 (es) Compuestos derivados de piridinona, inhibidores de bromodominio; composición farmacéutica que los comprende; y su uso en el tratamiento de enfermedades del cáncer. (solicitud divisional 201600925)
CL2017001209A1 (es) Inhibidor de cinasa aurora a
AR110381A2 (es) Inhibidores biarilo de tirosina cinasa de bruton
AR103680A1 (es) Inhibidores selectivos de bace1
PH12016502398A1 (en) Dihydropyrimido loop derivative as hbv inhibitor
MX380394B (es) Compuesto novedoso de bifenilo o una sal del mismo.
MX2017007629A (es) Compuestos inhibidores de bcl-xl que tienen una baja permeabilidad en las celulas y conjugados de anticuerpo-farmaco que los incluyen.
CR20150418A (es) Compuestos de tetrahidropirrolotiazina
AR098274A1 (es) Inhibidor de grelina o-acil transferasa
MX2023000418A (es) Fluorofenil beta-hidroxietilaminas y su uso en el tratamiento de la hiperglucemia.
CL2018001199A1 (es) Composiciones terapéuticas para el tratamiento del virus de inmunodeficiencia humana
CL2013002417A1 (es) Compuestos derivados de fluoropiridinona; composición farmacéutica que los comprende; y su uso en el tratamiento de infecciones bacterianas.
SG11201900868XA (en) Ido1 inhibitor and preparation method and application thereof
MX368496B (es) Análogos de compuestos de 4h-pirazolo[1,5-a]bencimidazol como inhibidores parp.
MX2017007607A (es) Inhibidores de necrosis celular y metodos relacionados.
AR105821A1 (es) COMPUESTOS ÚTILES PARA INHIBIR ROR-g-T
PH12019500370A1 (en) Triazolopyrazinone derivative useful as a human pde1 inhibitor
NI201800065A (es) Compuestos de 1,3,4-tiadiazol y su uso en el tratamiento de cáncer
AU2016351424A8 (en) Pyranodipyridine compound
MY193239A (en) Novel b-lactamase inhibitors
AR112346A1 (es) Derivados de [1,2,4]triazolo
AR106849A1 (es) Compuestos de bis-piridazina y su uso en el tratamiento del cáncer
PH12016500809B1 (en) Glucopyranosyl - substituted indole-urea derivatives and their use as sglt inhibitors
MX2016013428A (es) Composiciones farmaceuticas que comprenden agentes antibacterianos.

Legal Events

Date Code Title Description
FB Suspension of granting procedure